Research.Patient.info
Advanced Solid Tumors Cancer research hub
2 indexed studies · 1 currently recruiting
- recruitingPHASE1, PHASE2
A Study to Assess the Safety, Tolerability, and Efficacy of NDI-219216 in Patients With Advanced Solid Tumors.
This study is testing a new medicine, NDI-219216, for people with advanced solid cancers. Researchers want to see if it's safe, what side effects it might cause, and if it could help shrink tumours. It's an early-stage trial.
United States · Australia · Canada - active not recruitingPHASE1
Study to Determine the Safety, Tolerability, Pharmacokinetics and Recommended Phase 2 Dose (RP2D) of Livmoniplimab (ABBV-151) as a Single Agent and in Combination With Budigalimab (ABBV-181) in Participants With Locally Advanced or Metastatic Solid Tumors
This study is looking at two new drugs, Livmoniplimab and Budigalimab, for people with advanced cancers. It aims to find the safest and most effective dose, and see how well they work, both alone and together.
United States · Australia · Belgium